Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJG30
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,945
Award facts
- Contract value 100% obligated
- $11,945.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,945.32 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen auto-injectors on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. Dupixent is a specialty pharmaceutical used to treat various inflammatory conditions, reflecting the company's portfolio of brand-name medications serving federal healthcare needs. The underlying IDC vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support defense health programs, including the Defense Health Agency and U.S. Coast Guard. The company's competitive awards across multiple delivery orders demonstrate its capability to fulfill federal medical supply requirements across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJG30?
SPE2DB25FJG30 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FJG30 worth?
The government has obligated $11,945 on SPE2DB25FJG30.
Is contract SPE2DB25FJG30 an order under another contract?
Yes. SPE2DB25FJG30 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJG30 competed?
The extent of competition for SPE2DB25FJG30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award